A TRUSTED MANUFACTURING PROCESS• • • • • • • • • • • • • •
50 billion times a year, many of the world’s largest medical brands trust the Blow-Fill-Seal manufacturing process (BFS) to fill sterile containers with eye drops, nose sprays, and even oral vaccines (in ampoules).
A length of molten plastic is extruded from a machine and a jet of air blows an opening into it, forming a tube which is then sealed at the bottom.
In a faction of a second, a long needle-like nozzle fills the molten tube with medicine in precisely the dose needed.
Once the nozzle is removed, the tube container is sealed at the top and cooled almost instantly.
ANY SHAPE — FAST AND AFFORDABLE
BFS can create an infinite number of container shapes, allowing for unique designs to fit specific needs or marketing campaigns.
A single BFS machine can produce 34,000 ApiJect devices an hour and 275 million doses a year. Plus, its simple manufacturing process enables deliveries on short timetables.
SINGLE-DOSE IN INDIVIDUAL UNITS OR STRIPS.
ApiJect devices are delivered in individual units, or strips which can be easily broken apart for quick use or transport in a bag or pocket.
When stacked interlocking for shipment, they take up slightly more room than a multi-dose vial. However, the ApiJect device requires significantly less space than the traditional package: a multi-dose vial + reusable syringes.
WORLDWIDE NETWORK OF MANUFACTURERS
The components that make up a ApiJect device are produced by multiple manufacturing partners across the globe.
At launch, needle hubs will be produced in South Korea and India. BFS production and final assembly + packaging will take place in Switzerland, South Korea, or at the pharmaceutical company’s plant.
LESS ENERGY. LESS WASTE.
The BFS manufacturing process requires significantly less energy than glass manufacturing.
What’s more, a compact ApiJect creates less medical waste than a reusable syringe + glass vial. And, there is no broken glass to worry about.